A synthetic route to partly silylated tetra(silyl)methanes (ArH2Si)nC(SiH3)4 — n′ to their precursors (TfH2Si)nC‐(SiH2Ar)4 — n (Ar = p‐tolyl, phenyl; Tf = CF3SO3; n = 3, 2, 1), and to 1,3‐bis(trisilylmethyl)disiloxane [(H3Si)3CSiH2]2O (9) is reported. Starting from symmetrical tetrakis(arylsilyl)‐methanes (aryl = p‐tolyl, phenyl), we have obtained the selectively dearylated (arylsilyl)silylmethanes (ArH2Si)nC(SiH3)4 — n (Ar = p‐tolyl, phenyl; n = 3, 2, 1) by Si—Ar cleavage with equivalent quantities of trifluoromethanesulfonic acid (triflic acid) and hydrogenation of the corresponding silyl triflates (TfH2Si)nC(SiH2Ar)4 — n (n = 3, 2, 1) with LiAlH4. The synthesis of 9 has been accomplished by treating trisilyl(p‐tolylsilyl)methane p‐TolH2SiC(SiH3)3 (7) with stoichiometric amounts of triflic acid to give (trisilylmethyl)silyl triflate TfH2SiC(SiH3)3 (8) and hydrolysing the latter with water.
No takes yet. Share an insight, caveat, or question.
Bommers et al. (1994) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: